Skip to main content
. 2021 Oct 10;13(1):88–95. doi: 10.34172/apb.2023.007

Figure 3.

Figure 3

Inhibition of T lymphocytes caused by PD-L1 binding to PD-1 and mechanism of action of anti-PD-1 and anti-PD-L1 monoclonal antibodies.11,24,25